Not specified in abstract provided Pharmaceuticals (Basel, Switzerland)
Evaluating the need for maximum dose Not every patient needs the 2.4 mg dose
Clinical Considerations Disease-Associated Maternal And/Or Embryo/Fetal Risk Appropriate weight gain based on pre-pregnancy weight is currently recommended for all pregnant patients, including those with obesity or overweight, due to the obligatory weight gain that occurs in maternal tissues during pregnancy
Those medications target both GLP-1 and another gut hormone, GIP
Most people who take them see their diarrhoea improve, though side effects like bloating, constipation, or flatulence can make long-term use challenging for some
The injection is typically self-administered by the patient at home after an initial in-clinic training session